Reported 0 shares, down 100 (100.0%) from the prior quarter.
Reported value -100.0%; share count -100.0% vs. the prior quarter.
Reported position value by quarter
Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.
| Date | Holding Value |
|---|---|
| 2022-03-31 | 2000 |
| 2022-06-30 | 2000 |
| 2022-09-30 | 2000 |
| 2022-12-31 | 3000 |
| 2023-03-31 | 595 |
| 2023-06-30 | 0 |
Quarterly position history
How this manager's reported quarter-end position changed over time.
| Quarter | Activity | Shares | Change | % of reported 13F | Reported value | Filed | Source filing |
|---|---|---|---|---|---|---|---|
| Q2 2023 | Reduced | 0 | -100 (-100.0%) | 0 | $0 | 2023-08-04 | |
| Q1 2023 | Added | 100* | +86 (650.0%) | < 0.01% | $595 | 2023-04-18 | |
| Q4 2022 | Added | 400 | +100 (33.3%) | < 0.01% | $3,000 | 2023-02-07 | |
| Q3 2022 | Unchanged | 300 | 0 (0.0%) | < 0.01% | $2,000 | 2022-11-08 | |
| Q2 2022 | Unchanged | 300 | 0 (0.0%) | < 0.01% | $2,000 | 2022-08-12 | |
| Q1 2022 | New | 300 | +300 (0.0%) | < 0.01% | $2,000 | 2022-08-08 | |
|
Five years are shown. A free account unlocks the complete reported history.
Unlock full history
|
|||||||
Who else reported the position
3 managers reported CORBUS PHARMACEUTICALS HLDG for Q2 2023.
| Manager | Activity | Shares | Change | % of reported 13F | Reported value | Tenure |
|---|---|---|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES INC | Unchanged | 0 | 0 | 0 | $0 | 20 qtrs |
| IFP Advisors Inc This report | Reduced | 0 | -100 | 0 | $0 | 6 qtrs |
| CoreCap Advisors LLC | Reduced | 0 | -750 | 0 | $0 | 1 qtr |
Filing details and methodology As reported
- Report period
- June 30, 2023
- Filed
- August 04, 2023
- Filing type
- 13F-HR
- Position type
- cs
Voting authority reported
No voting-authority amounts were reported for this position. Voting authority is not required for reported call options.
Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.